1,183,773 Shares in Kestra Medical Technologies, Ltd. $KMTS Purchased by Alliancebernstein L.P.

Key Points

• Alliancebernstein L.P. made a significant investment in Kestra Medical Technologies, acquiring over 1.18 million shares valued at approximately $29.5 million, representing 2.31% ownership of the company.
• Several other investors, including Alyeska Investment Group and Adage Capital Partners, also bought new positions in Kestra Medical during the same period, indicating growing interest in the stock.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Kestra Medical Technologies, with recent price target adjustments from $28.00 to $27.00 by Wells Fargo.

Alliancebernstein L.P. bought a new position in shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,183,773 shares of the company's stock, valued at approximately $29,500,000. Alliancebernstein L.P. owned 2.31% of Kestra Medical Technologies as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in the company. Quarry LP purchased a new stake in shares of Kestra Medical Technologies during the first quarter worth approximately $33,000. Virtu Financial LLC purchased a new stake in Kestra Medical Technologies in the 1st quarter valued at $210,000. Armistice Capital LLC purchased a new stake in Kestra Medical Technologies in the 1st quarter valued at $312,000. Russell Investments Group Ltd. acquired a new stake in shares of Kestra Medical Technologies during the first quarter worth $457,000. Finally, Caas Capital Management LP acquired a new stake in shares of Kestra Medical Technologies during the first quarter worth $1,470,000.

Analysts Set New Price Targets

Separately, Wells Fargo & Company decreased their price target on Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating for the company in a report on Thursday, July 17th. Five research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $27.33.

Kestra Medical Technologies Trading Up 3.9%

Shares of KMTS stock traded up $0.85 during mid-day trading on Monday, reaching $22.68. The stock had a trading volume of 571,892 shares, compared to its average volume of 262,816. The firm's 50-day moving average is $16.61. Kestra Medical Technologies, Ltd. has a 12-month low of $13.25 and a 12-month high of $26.15. The company has a quick ratio of 6.72, a current ratio of 6.72 and a debt-to-equity ratio of 0.20.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.